↓ Skip to main content

The Qure study: Q fever fatigue syndrome – response to treatment; a randomized placebo-controlled trial

Overview of attention for article published in BMC Infectious Diseases, March 2013
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (75th percentile)
  • High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

twitter
8 X users
facebook
2 Facebook pages

Citations

dimensions_citation
28 Dimensions

Readers on

mendeley
86 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The Qure study: Q fever fatigue syndrome – response to treatment; a randomized placebo-controlled trial
Published in
BMC Infectious Diseases, March 2013
DOI 10.1186/1471-2334-13-157
Pubmed ID
Authors

Stephan P Keijmel, Corine E Delsing, Tom Sprong, Gijs Bleijenberg, Jos WM van der Meer, Hans Knoop, Chantal P Bleeker-Rovers

Abstract

Q fever is a zoonosis that is present in many countries. Q fever fatigue syndrome (QFS) is one of the most frequent sequelae after an acute Q fever infection. QFS is characterized by persistent fatigue following an acute Q fever infection, leading to substantial morbidity and a high socio-economic burden. The occurrence of QFS is well-documented, and has been described in many countries over the past decades. However, a treatment with proven efficacy is not available. Only a few uncontrolled studies have tested the efficacy of treatment with antibiotics on QFS. These studies suggest a positive effect of long-term treatment with a tetracycline on performance state; however, no randomized controlled trials have been performed. Cognitive behavioral therapy (CBT) has been proven to be an effective treatment modality for chronic fatigue in other diseases, but has not yet been tested in QFS. Therefore, we designed a trial to assess the efficacy of long-term treatment with the tetracycline doxycycline and CBT in patients with QFS.

X Demographics

X Demographics

The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 86 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
Unknown 85 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 13 15%
Researcher 12 14%
Student > Master 10 12%
Student > Ph. D. Student 9 10%
Student > Postgraduate 5 6%
Other 11 13%
Unknown 26 30%
Readers by discipline Count As %
Medicine and Dentistry 22 26%
Psychology 8 9%
Nursing and Health Professions 6 7%
Biochemistry, Genetics and Molecular Biology 4 5%
Pharmacology, Toxicology and Pharmaceutical Science 4 5%
Other 13 15%
Unknown 29 34%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 September 2023.
All research outputs
#6,148,557
of 24,450,293 outputs
Outputs from BMC Infectious Diseases
#1,869
of 8,177 outputs
Outputs of similar age
#48,461
of 201,401 outputs
Outputs of similar age from BMC Infectious Diseases
#23
of 136 outputs
Altmetric has tracked 24,450,293 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 8,177 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.5. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 201,401 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 136 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.